Largest Shareholder & CEO Kang Hee-chul Open Market Purchase
-
Largest shareholder and CEO Kang Hee-chul executed open market purchases during Apr 2-6, 2026. -
Perceived as a signal of management's confidence and view of undervaluation.
KOSDAQ Filing Information
- Filing: Report on Large Shareholding (General)
- Company: GFC Life Science (388610)
- Submission: Heecheol Kang
- Receipt: 04-08-2026